AbbVie sponsors new ABBV-253 solid tumor trial; collaborates on epcoritamab lymphoma studySep 10Weekly roundup, 2 itemsABBV-253AbbVie
AbbVie to acquire Apogee Therapeutics, updates 2026 EPS guidance amid Q2 resultsJul 31Quarterly updateAbbVie
AbbVie week: BOTOX oral pain results post; new CLL, myeloma, ABBV-859 trials filedJul 31Weekly roundup, 6 itemsABBV-859AbbVie
Genmab reports positive Phase 3 results for epcoritamab plus lenalidomide in DLBCLJun 29Clinical readoutepcoritamab-byspGenmab A/S
Sign inSign in